AIM ImmunoTech Inc.

NYSE
AIM
Stock
Yield per half year: -35.53%
Dividend yield: 0%
Sector: Healthcare

AIM ImmunoTech Inc.

0.39390.39390.33410.33410.27430.27430.21450.21450.15470.15470.09490.0949Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 52.65 -100% -3.93 -100%
P/S 69.2 4.03 1615.92%
P/BV -8.9 10.87 -181.88%
P/FCF 0 39.64 -100%
Ev/Ebitda -0.7886 16.1 -104.9%
Ev/S 76.49 4.35 1657.71%
Ev/FCF -0.8724 52.31 -101.67%
E/P 0 0.2095 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-9699.41 19.07 -50948.99% -10665.33 -9.06%
ROE -388.69 -83.32 366.5%
ROA -123.76 6.38 -2040.25%
ROIC 0 15.06 -100%
ROS -10188.24 9.34 -109236.05%
ROCE 1265.89 84.76 1393.48%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.1784 1.01 -117.7% -0.0859 +107.55%
Nеt Debt/Ebitda -0.0752 1.4 -105.38%
Debt/Ratio 0.3417 0.2742 24.62%
Debt/Equity -7.51 15.68 -147.91%
Debt/Net Income -0.1698 6.8 -102.5%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.28 -100% 0 0%
Number of years of dividend growth 0 6.75 -100%
DSI 1 0.7413 34.89%
Average dividend growth 0 -4.1 -100%
Average percentage for 5 years 0 1.33 -100%
Average percentage for payments 0 44.08 -100%
Difference from average difference in sector -1.28

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
4/10
21.43 12.47 71.85%
Growth impulse Ebitda in 5 years 54.16 -86.3 -162.76%
Growth impulse Net Income in 5 years 59.99 -75.86 -179.08%
Growth impulse FCF in 5 years 58.04 -79.28 -173.21%
Growth impulse EPS in 5 years -70.2 4.34 -1717.51%
IP Score
4.17/10

Similar companies

Bristol-Myers

Humana

UnitedHealth Group

Johnson & Johnson

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription